ARCTIC: Durvalumab + tremelimumab and durvalumab monotherapy vs SoC in ≥ 3L advanced NSCLC treatment
n/a
Published in: | Annals of Oncology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.openaccessrepository.it/record/45594 https://doi.org/10.1093/annonc/mdy292.001 |
Summary: | n/a |
---|